Methods for Implementing and Reporting Patient-reported Outcome (PRO) Measures of Symptomatic Adverse Events in Cancer Clinical Trials

Clinical Therapeutics

Volumn 38, Issue 4, 2016, Pages 821-830

  Basch, Ethan ^a,b   Rogak, Lauren J ^b   Dueck, Amylou C ^c  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c MAYO CLINIC   (United States)

Author keywords

Adverse event; Cancer; Common Terminology Criteria for Adverse Events; Key words Patient reported outcome; Symptom; Toxicity

Indexed keywords

ANTINEOPLASTIC AGENT;

ADVERSE OUTCOME; CANCER THERAPY; CLINICAL TRIAL (TOPIC); FUTUROLOGY; HEALTH CARE PLANNING; HUMAN; INFORMATION PROCESSING; OUTCOME ASSESSMENT; PATIENT REPORTED OUTCOME; PHASE 2 CLINICAL TRIAL (TOPIC); RECALL; REVIEW; STANDARD; STUDY DESIGN; SYSTEMATIC REVIEW; ADVERSE DRUG REACTION; DRUG SURVEILLANCE PROGRAM; NEOPLASMS; PATIENT-REPORTED OUTCOME; QUESTIONNAIRE;

ADVERSE DRUG REACTION REPORTING SYSTEMS; ANTINEOPLASTIC AGENTS; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; HUMANS; NEOPLASMS; PATIENT REPORTED OUTCOME MEASURES; SURVEYS AND QUESTIONNAIRES;

EID: 84961912420     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2016.03.011     Document Type: Article

References (31)

1. U.S. Department of Health and Human Services, Food and Drug Administration. Guidance for industry: Patient-reported outcomes measures: Use in medical product development to support labeling claims. December 2009. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM193282.pdf (last accessed January 21, 2016).
2. P.G. Kluetz, A. Slagle, E. Papadopoulos, and et al. Focusing on Core Patient-Reported Outcomes in Cancer Clinical Trials: Symptomatic Adverse Events, Physical Function, and Disease-Related Symptoms Clin Cancer Res 2016 [Epub ahead of print] PubMed PMID: 26758559
3. E. Basch The missing voice of patients in drug-safety reporting N Engl J Med 362 2010 865 869
4. National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services. Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0. NIH publication # 09-7473. Published May 29, 2009; Revised Version 4.03 June 14, 2010. http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE-4.03-2010-06-14-QuickReference-5x7.pdf. (last accessed March 16, 2015).
5. M. Di Maio, C. Gallo, N.B. Leighl, and et al. Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials J Clin Oncol 33 2015 910 915 PubMed PMID: 25624439
6. E. Basch, X. Jia, G. Heller, and et al. Adverse symptom event reporting by patients vs clinicians: relationships with clinical outcomes J Natl Cancer Inst 101 23 2009 1624 1632 PubMed PMID: 19920223; PubMed Central PMCID: PMC2786917
7. Basch E, Iasonos A, McDonough T, et al. Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study. Lancet Oncol. 2006;7:903-909. PubMed PMID: 17081915.
8. Reeve BB, Mitchell SA, Dueck AC, et al. Recommended patient-reported core set of symptoms to measure in adult cancer treatment trials. J Natl Cancer Inst. 2014;106. Print 2014 Jul. Review. PubMed PMID: 25006191; PubMed Central PMCID: PMC4110472.
9. E. Basch, A.P. Abernethy, C.D. Mullins, and et al. Recommendations for incorporating patient-reported outcomes into clinical comparative effectiveness research in adult oncology J Clin Oncol 30 2012 4249 4255
10. E. Basch, A.M. Deal, M.G. Kris, and et al. Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial J Clin Oncol 2015 [Epub ahead of print] PubMed PMID: 26644527
11. M. Cirillo, M. Venturini, L. Ciccarelli, and et al. Clinician versus nurse symptom reporting using the National Cancer Institute-Common Terminology Criteria for Adverse Events during chemotherapy: results of a comparison based on patient's self-reported questionnaire Ann Oncol 20 12 2009 1929 1935 Epub 2009 Jul 17. PubMed PMID: 19622510
12. S. Novello, E. Capelletto, D. Cortinovis, and et al. Italian multicenter survey to evaluate the opinion of patients and their reference clinicians on the "tolerance" to targeted therapies already available for non-small cell lung cancer treatment in daily clinical practice Transl Lung Cancer Res 3 3 2014 173 180 PubMed PMID: 25806297; PubMed Central PMCID: PMC4367690
13. F. Montemurro, G. Mittica, C. Cagnazzo, and et al. Self-Evaluation of Adjuvant Chemotherapy-Related Adverse Effects by Patients With Breast Cancer JAMA Oncol 2015 1 8 [Epub ahead of print] PubMed PMID: 26720497
14. E. Basch, B.B. Reeve, S.A. Mitchell, and et al. Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE) J Natl Cancer Inst 2014 106 Print 2014 Sep. PubMed PMID: 25265940; PubMed Central PMCID: PMC4200059
15. J.L. Hay, T.M. Atkinson, B.B. Reeve, et al. NCI PRO-CTCAE Study Group Cognitive interviewing of the US National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) Qual Life Res 23 1 2014 257 269 Epub 2013 Jul 20. PubMed PMID: 23868457; PubMed Central PMCID: PMC3896507
16. A.C. Dueck, T.R. Mendoza, S.A. Mitchell, et al. National Cancer Institute PRO-CTCAE Study Group Validity and Reliability of the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) JAMA Oncol 1 2015 1051 1059 PubMed PMID: 26270597
17. J.E. Broderick, J.E. Schwartz, G. Vikingstad, and et al. The accuracy of pain and fatigue items across different reporting periods Pain 139 2008 146 157
18. S. Schneider, J.E. Broderick, D.U. Junghaenel, and et al. Temporal trends in symptom experience predict the accuracy of recall PROs J Psychosom Res 75 2013 160 166 Epub 2013 Jul 6. PubMed PMID: 23915773; PubMed Central PMCID: PMC3740272
19. C.J. Gwaltney, A.L. Shields, and S. Shiffman Equivalence of electronic and paper-and-pencil administration of patient-reported outcome measures: a meta-analytic review Value Health 11 2008 322 333
20. Muehlhausen W, Doll H, Quadri N, et al. Equivalence of electronic and paper administration of patient-reported outcome measures: a systematic review and meta-analysis of studies conducted between 2007 and 2013. Health Qual Life Outcomes. 2015;13:167. PubMed PMID: 26446159; PubMed Central PMCID: PMC4597451.
21. A.V. Bennett, A.C. Dueck, S.A. Mitchell, et al. National Cancer Institute PRO-CTCAE Study Group Mode equivalence and acceptability of tablet computer-, interactive voice response system-, and paper-based administration of the U.S. National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) Health Qual Life Outcomes 14 2016 24 PubMed PMID: 26892667; PubMed Central PMCID: PMC4759776
22. S. Eremenco, S.J. Coons, J. Paty, and et al. ISPOR PRO Mixed Modes Task Force. PRO data collection in clinical trials using mixed modes: report of the ISPOR PRO mixed modes good research practices task force Value Health 17 2014 501 516 PubMed PMID: 25128043
23. E. Basch, W.A. Wood, D. Schrag, and et al. Feasibility and clinical impact of sharing patient-reported symptom toxicities and performance status with clinical investigators during a phase 2 cancer treatment trial Clin Trials 2015 [Epub ahead of print]
24. T.M. Atkinson, D.V. Satele, J.A. Sloan, and et al. Comparison between clinician- and patient-reporting of baseline (bl) and post-bl symptomatic toxicities in cancer cooperative group clinical trials (NCCTG N0591 [Alliance]) J Clin Oncol 2015 33
25. A. Trotti, T.F. Pajak, C.K. Gwede, and et al. TAME: development of a new method for summarising adverse events of cancer treatment by the Radiation Therapy Oncology Group Lancet Oncol 8 2007 613 624 PubMed PMID: 17543584
26. B. Klingenberg, and A. Agresti Multivariate extensions of McNemar's test Biometrics 62 3 2006 921 928 PubMed PMID: 16984337
27. H.J. van der Pal, E.C. van Dalen, E. van Delden, and et al. High risk of symptomatic cardiac events in childhood cancer survivors J Clin Oncol 30 2012 1429 1437 Epub 2012 Apr 2. PubMed PMID: 22473161
28. G. Thanarajasingam, J.M. Hubbard, J.A. Sloan, and et al. The Imperative for a New Approach to Toxicity Analysis in Oncology Clinical Trials J Natl Cancer Inst 2015 107 Print 2015 Oct. PubMed PMID: 26232762
29. C. Quinten, J. Maringwa, C.C. Gotay, and et al. Patient self-reports of symptoms and clinician ratings as predictors of overall cancer survival J Natl Cancer Inst 103 2011 1851 1858
30. M.L. Bell, and D.L. Fairclough Practical and statistical issues in missing data for longitudinal patient-reported outcomes Stat Methods Med Res 23 2014 440 459 Epub 2013 Feb 19. PubMed PMID: 23427225
31. B. Movsas, D. Hunt, D. Watkins-Bruner, and et al. Can electronic web-based technology improve quality of life data collection? Analysis of Radiation Therapy Oncology Group 0828 Pract Radiat Oncol 4 2014 187 191 Epub 2013 Sep 16. PubMed PMID: 24766686; PubMed Central PMCID: PMC4007315